Castleark Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
|
|||||
2022
Q4 | $13.5M | Sell |
|
|||||
2022
Q3 | $34.8M | Buy |
|
|||||
2022
Q2 | $39.3M | Buy |
|
|||||
2022
Q1 | $43.2M | Sell |
|
|||||
2021
Q4 | $50.1M | Sell |
|
|||||
2021
Q3 | $43.9M | Sell |
|
|||||
2021
Q2 | $45.5M | Buy |
|
|||||
2021
Q1 | $19.6M | Buy |
|
|||||
2020
Q4 | $20.2M | Sell |
|
|||||
2020
Q3 | $18.2M | Buy |
|
|||||
2020
Q2 | $13.8M | Buy |
|
|||||
2020
Q1 | $598K | Buy |
|
|||||
2019
Q4 | $336K | Sell |
|
|||||
2019
Q3 | $554K | Hold |
|
|||||
2019
Q2 | $466K | Sell |
|
|||||
2019
Q1 | $763K | Hold |
|
|||||
2018
Q4 | $611K | Sell |
|
|||||
2018
Q3 | $14M | Sell |
|
|||||
2018
Q2 | $25.8M | Buy |
|
|||||
2018
Q1 | $445K | Buy |
|
|||||
2017
Q4 | $277K | Buy |
|
|||||
2017
Q3 | $172K | Sell |
|
|||||
2017
Q2 | $11.5M | Sell |
|
|||||
2017
Q1 | $16.5M | Sell |
|
|||||
2016
Q4 | $30.5M | Sell |
|
|||||
2016
Q3 | $63.8M | Sell |
|
|||||
2016
Q2 | $55.6M | Sell |
|
|||||
2016
Q1 | $53.8M | Buy |
|
|||||
2015
Q4 | $44.8M | Sell |
|
|||||
2015
Q3 | $41M | Sell |
|
|||||
2015
Q2 | $42.8M | Buy |
|
|||||
2015
Q1 | $20M | Buy |
|